Although reduced cell viability is a similar aspect between different types of cancer, the versatility of AD80 allows it to act on various molecular targets, including S6K, RET, RAF, and p38 MAPK [7,8,9,10,11], making it an attractive multitarget compound. This evidence concerns the gene RET and cancer.